welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
completed

PoC Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With DMD

key information

study id #: NCT02858362

condition: Duchenne Muscular Dystrophy

status: completed

purpose:

A Phase 2 Clinical Study to Assess the Activity and Safety of Utrophin Modulation with SMT C1100 (ezutromid) in Ambulatory Paediatric Male Subjects with Duchenne Muscular Dystrophy (DMD)

intervention: ezutromid

mechanism of action: Utophin modulator to promote utophin production

results: https://clinicaltrials.gov/ct2/show/results/NCT02858362

last updated: May 15, 2019